Comparison of Two Methods of Subscapularis Management in Shoulder Arthroplasty: Tenotomy Versus Peel
1 other identifier
interventional
100
1 country
1
Brief Summary
What is the difference in subscapularis strength between two different methods of subscapularis mobilization: incision of the tendon (tenotomy) versus peel. It is the investigators' hypothesis that a peel of the subscapularis will result in greater strength, a higher healing rate, and a greater improvement in shoulder function and quality of life following shoulder replacement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 26, 2011
CompletedFirst Posted
Study publicly available on registry
July 27, 2011
CompletedStudy Start
First participant enrolled
August 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedMay 17, 2021
May 1, 2021
6.1 years
July 26, 2011
May 14, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
What is the difference in subscapularis strength between two different methods of subscapularis mobilization: incision of the tendon (tenotomy) versus peel
What is the difference in subscapularis strength between two different methods of subscapularis mobilization: incision of the tendon (tenotomy) versus peel, as measured by a hand-held dynamometer in the belly-press position at one year post operative?
12 months
Secondary Outcomes (1)
Quality of life as measured by WORC, ASES and Constant
12 months
Study Arms (2)
Subscapularis Tenotomy
ACTIVE COMPARATORThis treatment group will undergo a technique that involves division of the tendon to gain access to the shoulder. After the deltopectoral approach is completed, the subscapularis tendon will be tenotomized one centimeter medial to its insertion on the lesser tuberosity.
Subscapularis Peel
EXPERIMENTALThis treatment group will use a technique that involves elevation of the tendon off the bone in order to gain access to the shoulder.The subscapularis will be elevated from the lesser tuberosity.
Interventions
After the deltopectoral approach is completed, the subscapularis tendon will be tenotomized one centimeter medial to its insertion on the lesser tuberosity. The tendon will be tagged for later repair. Repair will take place with a combination of transosseous sutures (3) placed in a mattress configuration through the area of exposed lesser tuberosity. In addition, a soft tissue tendon to tendon repair will be carried out using figure-8 stitches using #2 (heavy) non-absorbable suture (Ticron).
The subscapularis will be elevated from the lesser tuberosity. The tendon will be tagged with stay sutures for later reattachment (3 sutures in mattress configuration). Reapproximation will take place with three non-absorbable mattress sutures placed in a trans-osseous fashion through the bicipital groove, exiting the greater tuberosity and tied over a 4-hole mini-fragment plate.
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- Imaging, and intra-operative findings confirming advanced humeral head cartilage loss, and/glenoid cartilage loss.
- Ability to understand and adhere to rehab protocols and testing procedure
- Persistent pain and functional disability for at least 6 months and failure of 6 months of conservative treatment
- surgical arthroplasty patients
You may not qualify if:
- Active joint of systemic infection
- Significant muscle paralysis
- Rotator cuff tear arthropathy
- Pregnancy
- Charcot's arthropathy
- Major medical illness ( life expectancy less then 1 year or unacceptably high operative risk)
- Patients unable to provide informed consent due to language barrier or mental status
- Unable to speak or read English/French
- Psychiatric illness that precludes informed consent
- Patients unwilling to be followed for the duration of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ottawa Hospital Research Institutelead
- St. Joseph's Health Care Londoncollaborator
- Unity Health Torontocollaborator
Study Sites (1)
The Ottawa Hospital
Ottawa, Ontario, K1H 8L6, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Lapner, MD
The Ottawa Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 26, 2011
First Posted
July 27, 2011
Study Start
August 1, 2011
Primary Completion
September 1, 2017
Study Completion
September 1, 2017
Last Updated
May 17, 2021
Record last verified: 2021-05